Rexahn Pharma (RNN) Reports Q1 Loss of $0.02
Tweet
Share
E-mailGet Alerts RNN Hot Sheet
Join SI Premium – FREE
Rexahn Pharma (NYSE: RNN) reported Q1 EPS of ($0.02), versus ($0.02) reported last year.
For earnings history and earnings-related data on Rexahn Pharma (RNN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Iridex Corp (IRIX) Misses Q2 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
